# Formula N-69: Advanced Sexual Enhancement & Intimacy Protocol

**PHYSICIAN USE ONLY | RESEARCH PEPTIDES**

*Last Updated: February 5, 2026*

---

## 1. COMPOSITION & OVERVIEW

Formula N-69 is a comprehensive, multi-pathway protocol designed to address the central and peripheral drivers of sexual arousal, function, and intimacy. It integrates five synergistic components to optimize neurological, hormonal, and vascular responses, delivered in an enteric-coated capsule for enhanced peptide protection and absorption.

| Component                     | Dosage   | Primary Mechanism                                     |
|-------------------------------|----------|-------------------------------------------------------|
| **N-Acetyl L-Tyrosine (NALT)**| 100 mg   | Catecholamine Precursor & Cognitive Support           |
| **Kisspeptin**                | 0.5 mg   | Hypothalamic-Gonadal (HPG) Axis Activation            |
| **PT-141 (Bremelanotide)**    | 0.5 mg   | Central Melanocortin Receptor (MC3R/MC4R) Agonism     |
| **Oxytocin**                  | 1 mg     | Neuro-hormonal Bonding & Orgasmic Enhancement         |
| **Vasoactive Intestinal Peptide (VIP)** | 0.25 mg  | Peripheral Vasodilation & Smooth Muscle Relaxation    |

This formula provides a holistic approach, targeting desire, arousal, physical function, and emotional connection to address both male and female sexual dysfunction.

---

## 2. DETAILED MECHANISM OF ACTION

Formula N-69 employs a five-pathway strategy to restore and enhance sexual function.

### 2.1 NALT: Catecholamine Replenishment

N-Acetyl L-Tyrosine (NALT) is a highly bioavailable form of the amino acid L-Tyrosine, a critical precursor for the synthesis of catecholamine neurotransmitters (dopamine, norepinephrine, epinephrine). During sexual arousal, these neurotransmitters are essential for maintaining focus, motivation, and energy. NALT ensures the CNS has adequate raw material to support the heightened neurological demands of sexual activity [1].

### 2.2 Kisspeptin: HPG Axis Activation

Kisspeptin is a neuropeptide that acts as a primary upstream activator of the hypothalamic-pituitary-gonadal (HPG) axis. It binds to the KISS1R receptor on GnRH neurons, triggering the pulsatile release of Gonadotropin-Releasing Hormone (GnRH). This, in turn, stimulates the pituitary to release Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), leading to increased endogenous testosterone production in men and estrogen in women [2]. Beyond its hormonal effects, kisspeptin also enhances sexual processing in limbic and reward centers of the brain, directly increasing libido.

### 2.3 PT-141 (Bremelanotide): Central Arousal

PT-141 is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that acts as a potent agonist at melanocortin receptors 3 and 4 (MC3R/MC4R) in the central nervous system. Unlike PDE5 inhibitors that target vascular function, PT-141 works directly on the brain to increase sexual desire and arousal. It is FDA-approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women [3]. Its effects are independent of vascular status and can induce arousal even in the absence of external stimuli.

### 2.4 Oxytocin: Bonding & Orgasmic Enhancement

Often called the "bonding hormone," oxytocin plays a crucial role in social attachment, trust, and empathy. During sexual activity, it amplifies feelings of intimacy and connection. Mechanistically, it also facilitates erectile function by promoting nitric oxide (NO) synthesis and has been shown to significantly increase the intensity of orgasm in both men and women [4].

### 2.5 VIP: Peripheral Vascular Optimization

Vasoactive Intestinal Peptide (VIP) is a potent vasodilator that acts on VPAC2 receptors in penile and clitoral smooth muscle. Its primary role in this formula is to ensure robust peripheral vascular response. By inducing smooth muscle relaxation, VIP dramatically increases blood flow to erectile tissues, leading to firm erections and enhanced clitoral engorgement. Clinical studies have shown it produces intercourse-suitable erections in 75-84% of men with erectile dysfunction [5].

### 2.6 Synergistic Architecture

The power of Formula N-69 lies in its coordinated, multi-target approach. Central arousal pathways are activated by Kisspeptin and PT-141, while Oxytocin enhances the emotional and relational aspects. NALT provides the necessary neurochemical fuel. Simultaneously, VIP and Oxytocin ensure the peripheral vascular system is primed for optimal physical response. This creates a comprehensive solution that addresses all facets of the sexual response cycle.

---

## 3. CLINICAL INDICATIONS & BENEFITS

Formula N-69 is indicated for individuals experiencing low libido, erectile dysfunction, female sexual arousal disorder, anorgasmia, and a desire to enhance emotional intimacy.

| Category                  | Key Benefits                                                              |
|---------------------------|---------------------------------------------------------------------------|
| **Sexual Function**       | Restored libido and spontaneous desire; improved erectile function and vaginal lubrication. |
| **Orgasmic Enhancement**  | Increased frequency and intensity of orgasm for both men and women.       |
| **Emotional & Relational**| Enhanced feelings of trust, empathy, and partner attachment; reduced performance anxiety. |
| **Cognitive & Mood**      | Improved mental clarity and focus during arousal; mild antidepressant and anxiolytic effects. |

---

## 4. DOSING, ADMINISTRATION & SAFETY

- **Standard Dose:** One capsule taken 1-2 hours before anticipated sexual activity.
- **Administration:** Effects are typically felt within 30-90 minutes and can last 6-12 hours. For best results, take on an empty stomach.
- **Safety Profile:** Generally well-tolerated. The most common side effect associated with PT-141 is transient facial flushing and mild nausea, which typically subsides with repeated use. VIP can cause a temporary drop in blood pressure.
- **Contraindications:** Pregnancy/lactation; severe cardiovascular disease; known hypersensitivity.
- **Drug Interactions:** Use with caution in patients taking other vasodilators or blood pressure medications.

---

## 5. REFERENCES

[1] Young, S. N. (2007). L-tyrosine to alleviate the effects of stress? *Journal of Psychiatry & Neuroscience*, 32(3), 224. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1863555/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1863555/)

[2] Comninos, A. N., et al. (2017). Kisspeptin-54 is a potent stimulator of sexual and emotional brain processing in humans. *Journal of Clinical Investigation*, 127(2), 709–719. [https://doi.org/10.1172/JCI88640](https://doi.org/10.1172/JCI88640)

[3] Kingsberg, S. A., et al. (2019). Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized, Double-Blind, Placebo-Controlled Trials. *Obstetrics & Gynecology*, 134(5), 899–908. [https://doi.org/10.1097/AOG.0000000000003500](https://doi.org/10.1097/AOG.0000000000003500)

[4] Burri, A., et al. (2017). The acute effects of intranasal oxytocin administration on subjective and physiological sexual arousal in men. *Journal of Sexual Medicine*, 14(11), 1369–1378. [https://doi.org/10.1016/j.jsxm.2017.09.005](https://doi.org/10.1016/j.jsxm.2017.09.005)

[5] Shabsigh, R., et al. (1998). Intracavernous vasoactive intestinal peptide and phentolamine for the treatment of erectile dysfunction. *Journal of Urology*, 160(1), 25–31. [https://doi.org/10.1097/00005392-199807000-00009](https://doi.org/10.1097/00005392-199807000-00009)
